Variant Phenotype Annotation
证据URL
https://www.pharmgkb.org/variantAnnotation/1043818357
总结
CYP2C19 *3 is associated with increased risk of high on-treatment platelet reactivity when treated with aspirin and clopidogrel in patients undergoing PCI as compared to CYP2C19 *1/*1.